Pharmaceutical Technology

FEBRUARY 15, 2023

But the mRNA technology is not yet mature and there are no standardised manufacturing protocols yet. Some of the variables include the chemical composition of the LNP, the manufacturing process and of course the RNA itself, whose design and production must elicit the intended therapeutic outcome.” weight abundance.

Bioassay 130

Bioassay RNA Development Drugs 130

Camargo

MAY 2, 2021

Rapid scientific advances have put the cell and gene therapy field at the forefront of biomedical research. Obtain initial, nonbinding advice regarding chemistry, manufacturing, and controls (CMC), pharmacology and toxicology, and/or the clinical aspects of a development program. Scope and Topics: INTERACT vs Pre-IND Meetings.

Gene Therapy 155

Gene Therapy Gene Packaging Packaging 155

BioTech 365

OCTOBER 20, 2020

CHICAGO & MUNICH–(BUSINESS WIRE)–#Antibodies–Proteintech, the benchmark in antibodies, today announces the acquisition of ChromoTek, a manufacturer of Camelid, single-domain antibodies, also known as nanobodies. … Continue reading →

Antibody 40

Antibody Reagent Manufacturing Marketing 40

XTalks

AUGUST 18, 2020

The test has been developed by researchers at the Yale School of Public Health and is being touted as a game changer for fast and easy COVID testing. Having a test that requires less reagents and resources, such as the RNA extraction kits, increases capabilities for increased testing. Non-Proprietary Technology.

FDA Approval 90

FDA Approval Reagent RNA Genomics 90

Roots Analysis

FEBRUARY 13, 2023

As a result, there is an evident increase in the demand for mRNA manufacturing capacity. Application of Synthetic mRNA Several studies conducted by healthcare companies and research institutions have demonstrated the potential of mRNA.

Manufacturing 52

Manufacturing Drug Delivery Systems Genetic Engineering RNA 52

The Pharma Data

MARCH 20, 2021

The Challenge: The demands of many labs simultaneously beginning COVID-19 screening programs are leading to a scarcity of resources like pipette tips and reagents. Medicine in Oxford, Biogazelle, a biotechnology company in Ghent, and the Centre For Proteome Research at the University of Liverpool. delays where reagents are in.

Reagent 52

Reagent RNA Bioinformatics Medicine 52

The Pharma Data

JANUARY 24, 2021

25, 2021 (GLOBE NEWSWIRE) — Calibre Scientific is pleased to announce the acquisition of AIT France (“AIT”), a manufacturer and distributor of innovative consumables for analytical chemistry and chromatography. Headquartered in Paris, France, AIT supplies public and private researchers and pharmaceutical laboratories.

Life Science 52

Life Science Reagent Production Manufacturing 52

The Pharma Data

OCTOBER 27, 2020

.” With the panel’s authorization, Agena also aims to alleviate material shortages, enabling laboratories to accelerate testing without concerns about instrument or reagent availability. Agena Bioscience develops, manufactures, and supplies genetic analysis systems and reagents, including the MassARRAY ® System.

Genetic Analysis 52

Genetic Analysis Genomics Genome Reagent 52

XTalks

JUNE 27, 2022

CerTest Biotec specializes in the development and manufacturing of in vitro diagnostic medical devices and has expertise in the detection of human diseases. While Roche’s monkeypox tests are not commercially available yet, they are available to scientists in most countries for research use.

Development 83

Development In-Vitro Reagent Vaccine 83

Roots Analysis

FEBRUARY 21, 2022

Advancement in DNA sequencing technologies have resulted in noteworthy developments in various healthcare-related research fields, such as diagnostics and personalized medicine. Moreover, the manual protocols require extensive manipulation, costly reagents and long duration of skilled genomic library production.

Marketing 52

Marketing Gene Sequencing DNA Genomics 52

The Pharma Data

MAY 17, 2021

Academic centers should establish risk management programs to successfully commercialize cell and gene therapy products and to be a viable partner with contract research organizations (CROs) and manufacturers in developing these therapies. . Euro Convergence Programme. . © 2021 Regulatory Affairs Professionals Society.

Development 52

Development Gene Therapy Manufacturing Gene 52

Roots Analysis

FEBRUARY 23, 2022

NGS has emerged as an evolutionary technology in modern biotechnology and healthcare research, enabling researchers to develop a better understanding of the cause and consequences of disease. During our research, we came across more than 280 NGS library preparation kits, that are presently available in the market. Web: [link].

Genetics 52

Genetics DNA RNA Reagent 52

FDA Law Blog

AUGUST 3, 2022

If anything, the announcement was remarkably inconspicuous: a seemingly throwaway sentence in a draft compliance policy guide for research use only and investigational use only products. At the same time, FDA’s basic operational stance hasn’t changed much either.

In-Vitro 98

In-Vitro Regulation Production Compliance 98

The Pharma Data

SEPTEMBER 8, 2021

The acquisition enables Roche to further expand the portfolio of currently over 45 CE-IVD assays and more than 100 research use assays on Roche`s LightCycler PCR instruments. TIB Molbiol is a biotech company that has supplied the global market with reagents for research and medical diagnostics for over 30 years.

Genotype 52

Genotype Reagent Genetics Research 52

Advarra

NOVEMBER 29, 2022

The field of cell and gene therapies (CGT) is constantly evolving, and there has been significant progress in this area of research. Dealing with confusing regulatory guidelines is one of the top obstacles researchers face as they develop CGT products 1. Recent Problems in Cell and Gene Therapy Development.

Gene Therapy 52

Gene Therapy Gene Production Clinical Trials 52

Roots Analysis

AUGUST 15, 2023

These expression systems utilize bio machinery harvested from the lysate of disrupted cells for the manufacturing of a wide array of macromolecular and small molecule products.

Protein 52

Protein In-Vitro Production Reagent 52

The Pharma Data

DECEMBER 2, 2020

Howard Mayer, Ipsen’s head of research and development, called the Fast Track designation for Onivyde “an extension of Ipsen’s focus and contribution” to the oncology landscape. The license from ERS Genomics now enables Vivlion to offer both R&D reagents and screening services to its customers worldwide. in Mainland China.

Drugs 52

Drugs Gene Editing Genomics Genome 52

The Pharma Data

MARCH 16, 2022

Roche and its subsidiary, Tib Molbiol, confirm that it has tests for research use that identify the SARS-CoV-2 subvariants of concern, Omicron: BA.1, It’s critical to quickly and accurately identify variants to inform ongoing research – including the ongoing development of therapeutics and vaccines. 3 and Delta.

In-Vitro 52

In-Vitro Genotype Reagent Protein 52

Advarra

OCTOBER 1, 2024

Managing clinical trial budgets efficiently is necessary for the success and sustainability of clinical research sites. It’s difficult to calculate a clinical trial’s ROI if the potential research outcomes are unknown. However, a strong focus on cost-effective budget management can help research sites maximize their ROI.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Compliance 52

XTalks

OCTOBER 19, 2023

They typically work in the biotechnology, pharmaceutical and diagnostic sectors as well as in academic research, having pivotal roles in the early stages of drug discovery, research and diagnostic tool development by creating reliable tests that can provide essential data on biological samples. Stay Updated: Science is always evolving.

Scientist 59

Scientist Development Research Compliance 59

The Pharma Data

DECEMBER 23, 2020

The agreement includes a £500,000 upfront payment to Avacta which gives Astrea the rights to generate and develop Affimer reagents in-house for affinity separation. Ilya Pharma – Sweden’s Ilya Pharma announced it extended its research collaboration in immunophysiology with Uppsala University. It is a division of Gamma Biosciences.

Drugs 52

Drugs Licensing Licensing Vaccine 52

The Pharma Data

OCTOBER 14, 2020

AOP anticipates new opportunities in Austria as a hub for research and business. The AOP Orphan Group manufactures 80% of its drugs in Europe and has more than 20 subsidiaries and representative offices across the whole of Europe as well as in the United Arab Emirates and Israel. Axol Bioscience – Based in the U.K., Ltd of Japan.

Clinical Trials 52

Clinical Trials Clinical Trials Manufacturing In-Vivo 52

FDA Law Blog

SEPTEMBER 21, 2022

The monkeypox test policy describes how FDA will prioritize review of EUA requests for monkeypox tests, stating that FDA intends to focus on requests for high-throughput tests, tests with home specimen collection, or rapid diagnostic tests, all from experienced developers with high manufacturing capacity.

In-Vitro 52

In-Vitro Development Reagent Manufacturing 52

Roots Analysis

OCTOBER 16, 2023

This has enabled several researchers to study genetic disorders more precisely and closely. Further, the labor and reagent cost incurred in cloning procedures is reduced with customized cloning. Along with this, the high quality DNA clones and gene clones are customized as per the need and requirement.

DNA 40

DNA Gene Protein In-Vitro 40

The Pharma Data

MAY 15, 2023

Huebscher , non-executive board member in companies, institutions and former CEO of Solvias Group, a Swiss contract research firm, which she led between 2014 and 2021. She is also a board member at BBI Solutions, a UK based diagnostic reagents and a Novo Holdings company. The new board members are: Dr. Karen J.

Sales 40

Sales Production Doctors Doctor 40

XTalks

JANUARY 6, 2025

Whether its the integration of nanotechnology in medicine, the evolution of point-of-care (POC) diagnostics or the transformative impact of CRISPR and regenerative medicine, these biotech trends are pushing scientific boundaries and creating new opportunities for businesses and researchers alike. billion by 2031.

Gene Therapy 111

Gene Therapy RNA Gene Editing Gene 111

XTalks

MARCH 11, 2025

Dr. Erica Dawson Chief Research and Development Officer InDevR In this Xtalks Spotlight interview, Dr. Erica Dawson, Chief Research and Development Officer at InDevR, shared her insights on the current landscape of mRNA analytics and the potential breakthroughs that could support the future of multivalent vaccine development.

Vaccination 64

Vaccination Vaccine Development Manufacturing 64

Roots Analysis

JANUARY 27, 2025

Large-scale Production: When the proteins are successfully active, the processes are scaled up to meet the demands of large-scale research or industrial applications, ensuring the production of functional proteins in substantial quantities. Authors Bio Akarshika Singh is a business research analyst and competitive intelligence professional.

Protein 40

Protein Reagent Marketing Gene 40